BFV activates the NF-kappaB pathway through its transactivator (BTas) to enhance viral transcription (Q39736138)

14 September 2017

title

BFV activates the NF-kappaB pathway through its transactivator (BTas) to enhance viral transcription (English)

1 reference

14 September 2017

0 references

Jian Wang

1

1 reference

14 September 2017

Juan Tan

2

1 reference

14 September 2017

Xihui Zhang

3

1 reference

14 September 2017

Hongyan Guo

4

1 reference

14 September 2017

Qicheng Zhang

5

1 reference

14 September 2017

Tingting Guo

6

1 reference

14 September 2017

Yunqi Geng

7

1 reference

14 September 2017

Wentao Qiao

8

1 reference

14 September 2017

language of work or name

English

0 references

publication date

23 February 2010

1 reference

14 September 2017

number of pages

9

1 reference

based on heuristic

inferred from page(s)

published in

Virology

1 reference

14 September 2017

volume

400

1 reference

14 September 2017

issue

2

1 reference

14 September 2017

page(s)

215-223

1 reference

Series introduction: the transcription factor NF-kappaB and human disease

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.035

The two NF-kappaB activation pathways and their role in innate and adaptive immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.035

Binding of HIV-1 to its receptor induces tyrosine phosphorylation of several CD4-associated proteins, including the phosphatidylinositol 3-kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.035

Characterization of new simian foamy viruses from African nonhuman primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.035

The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.035

Foamy viruses--a world apart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.035

Herpes virus proteins ICP0 and BICP0 can activate NF-kappaB by catalyzing IkappaBalpha ubiquitination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.035

Activation of c-Jun N-terminal kinase (JNK) pathway by HSV-1 immediate early protein ICP0.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.035

Missing pieces in the NF-kappaB puzzle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.035

NF-kappaB activation by double-strand breaks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.035

Differential effects of I kappa B molecules on Tat-mediated transactivation of HIV-1 LTR

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.035

NF-kappaB and the innate immune response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.035

Isolation and sequencing of infectious clones of feline foamy virus and a human/feline foamy virus Env chimera

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.035

7 January 2021

Signaling to NF-kappaB

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.035

Isolation, cloning, and sequencing of simian foamy viruses from chimpanzees (SFVcpz): high homology to human foamy virus (HFV).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.035

Properties of human foamy virus relevant to its development as a vector for gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.035

Hostile takeovers: viral appropriation of the NF-kB pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.035

Activation of the I kappa B alpha kinase (IKK) complex by double-stranded RNA-binding defective and catalytic inactive mutants of the interferon-inducible protein kinase PKR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.035

Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.035

NF-kappaB at the crossroads of life and death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.035

To be, or not to be: NF-kappaB is the answer--role of Rel/NF-kappaB in the regulation of apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.035

Further characterization of equine foamy virus reveals unusual features among the foamy viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.035

Why aren't foamy viruses pathogenic?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.035

Molecular pathways in virus-induced cytokine production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.035

Foamy virus infection in primates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.035

An inducible transcription factor activates expression of human immunodeficiency virus in T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.035

HSV-1-inducible proteins bind to NF-kappa B-like sites in the HSV-1 genome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.035

NF-kappaB and virus infection: who controls whom

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.035

Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.035

RNA interference directed against viral and cellular targets inhibits human immunodeficiency Virus Type 1 replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.035

NF-kappaB: a key role in inflammatory diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.035

IFP35 is involved in the antiviral function of interferon by association with the viral tas transactivator of bovine foamy virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.035

Isolation and characterization of an equine foamy virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.035

Chemoresistance: impact of nuclear factor (NF)-kappaB inhibition by small interfering RNA. Commentary re J. Guo et al., Enhanced chemosensitivity to irinotecan by RNA interference-mediated down-regulation of the NF-kappaB p65 subunit. Clin Cancer Re

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.035

Sustained induction of NF-kappa B is required for efficient expression of latent human immunodeficiency virus type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.035

Domain-specific interaction with the I kappa B kinase (IKK)regulatory subunit IKK gamma is an essential step in tax-mediated activation of IKK.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.035

Retroviral oncoprotein Tax induces processing of NF-kappaB2/p100 in T cells: evidence for the involvement of IKKalpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.01.035

10.1016/J.VIROL.2010.01.035

7 January 2021

Identifiers

DOI

1 reference

14 September 2017

1 reference